Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia.

Archive ouverte

Dogliotti, I. | Jiménez, C. | Varettoni, M. | Talaulikar, D. | Bagratuni, T. | Ferrante, M. | Pérez, J. | Drandi, D. | Puig, N. | Gilestro, M. | García-Álvarez, M. | Owen, R. | Jurczak, W. | Tedeschi, A. | Leblond, Veronique | Kastritis, E. | Kersten, M. J. | d'Sa, S. | Kaščák, M. | Willenbacher, W. | Roccaro, A. M. | Poulain, Stéphanie | Morel, Pierre | Kyriakou, C. | Fend, F. | Vos, J. M. I. | Dimopoulos, M. A. | Buske, C. | Ferrero, S. | García-Sanz, R.

Edité par CCSD ; Springer Nature -

International audience. The diagnosis of Waldenström’s macroglobulinemia (WM), an IgM-associated lymphoplasmacytic lymphoma, can be challenging due to the different forms of disease presentation. Furthermore, in recent years, WM has witnessed remarkable progress on the diagnostic front, as well as a deeper understanding of the disease biology, which has affected clinical practice. This, together with the increasing variety of tools and techniques available, makes it necessary to have a practical guidance for clinicians to perform the initial evaluation of patients with WM. In this paper, we present the consensus recommendations and laboratory requirements for the diagnosis of WM developed by the European Consortium of Waldenström’s Macroglobulinemia (ECWM), for both clinical practice as well as the research/academical setting. We provide the procedures for multiparametric flow cytometry, fluorescence in situ hybridization and molecular tests, and with this offer guidance for a standardized diagnostic work-up and methodological workflow of patients with IgM monoclonal gammopathy of uncertain significance, asymptomatic and symptomatic WM.

Suggestions

Du même auteur

SARS-CoV-2 Infection in Patients With Waldenström's Macroglobulinemia: A Multicenter International Cohort Study.

Archive ouverte | Defrancesco, I. | CCSD

International audience

Report of consensus panel 7 from the 11th international workshop on Waldenström macroglobulinemia on priorities for novel clinical trials.

Archive ouverte | Tam, C. S. | CCSD

International audience. Recent advances in the understanding of Waldenström macroglobulinemia (WM) biology have impacted the development of effective novel agents and improved our knowledge of how the genomic backgr...

Report of consensus panel 5 from the 11th international workshop on Waldenstrom's macroglobulinemia on COVID-19 prophylaxis and management.

Archive ouverte | Terpos, E. | CCSD

International audience. Consensus Panel 5 (CP5) of the 11th International Workshop on Waldenstrom's Macroglobulinemia (IWWM-11; held in October 2022) was tasked with reviewing the current data on the coronavirus dis...

Chargement des enrichissements...